Nasdaq: MDLN · Listed Dec 17, 2025
Medline IPO
IPO price
$29.00
Medline (MDLN) priced its IPO at $29.00 a share and has traded on Nasdaq since Dec 17, 2025.
MDLN today$39.40+35.84%since IPO15-min delayed · as of 5:03:51 AM EST on Nov 19, 2026
See the MDLN quoteFirst trading day · Dec 17, 2025
- IPO price
- $29.00
- inside the range of $26 to $30
- First trade
- $35.00
- +20.69% from the IPO price
- First-day last trade
- $40.66
- +40.21% from the IPO price, regular session
- Raise
- $7.2B
- before the underwriters' option. Tick marks Alibaba '14
These numbers are from the first trading day, Dec 17, 2025.
How MDLN did against the market
MDLN against the market, from its first trade at 12:50 ET to the last trade of the session.
- MDLN from its first trade
- +16.17%
- Against the market (QQQ)
- +16.7 pts
MDLN rose 16.2% from its first trade to the last trade of the session. That is 16.7 points better than the market.
Same-day moves do not show that MDLN caused them. The market is QQQ, the Nasdaq-100 ETF.
The debut race
MDLN against other big listings, as the percent change from each stock's own IPO price.
The first 30 trading days. Each point is the last regular-session trade of a day.
The first trading day.
The first trading day.
The IPO scoreboard
MDLN against 6 other big listings: the return from each IPO's own price at the first trade, the close of day 1, day 5, and day 30.
| IPO | Raised | First trade | Day 1 close | Day 1 close, as a bar | Day 5 | Day 30 |
|---|---|---|---|---|---|---|
| Medline '25 | $7.2B | +20.69% | +40.21% | +50.36% | +52.31% | |
| Figma '25 | $1.22B | +157.58% | +252.42% | +173.64% | +69.64% | |
| Circle '25 | $1.05B | +122.58% | +168.45% | +278.18% | +622.98% | |
| Reddit '24 | $748M | +38.24% | +47.97% | +69.90% | +40.32% | |
| Arm '23 | $5.23B | +10.00% | +23.76% | +3.63% | -3.06% | |
| Klarna '25 | $1.37B | +30.00% | +16.14% | +13.73% | -7.33% | |
| CoreWeave '25 | $1.5B | -2.50% | +0.02% | +34.32% | +28.42% |
Day 1 is the last regular-session trade of the first day. Day 5 and day 30 are the last trade of the fifth and thirtieth trading day, counting the listing day as day 1. A cell fills in when that day has traded.
The offering
The Medline IPO offers 248.44M shares to raise $7.2B, before any underwriters' option.
- Expected price range
- $26 to $30
- IPO price
- $29.00
- Shares offered
- 248.44M
- Money raised
- $7.2B
- Listing date
- Dec 17, 2025
- Exchange
- Nasdaq
- Security
- Ordinary Shares - Class A
Money raised, against the largest IPOs
- Alibaba '14$21.77B
- Facebook '12$18.41B
- Rivian '21$11.93B
- Uber '19$8.1B
- Medline$7.2B
- Arm '23$5.23B
Where MDLN ranks
Medline's market cap against the largest US-listed companies.
Market cap, against the largest US-listed companies
- AAPL$5.12T
- MSFT$3.77T
- NVDA$3.65T
- GOOGL$3.47T
- AMZN$2.9T
- TSM$1.88T
- AVGO$1.69T
- META$1.58T
- TSLA$1.52T
- BRK.B$1.22T
- MDLN$34.41B
MDLN news
The latest news and headlines about Medline (MDLN).
- Medline Inc. announces pricing of secondary offering of Class A common stockneutralGlobeNewswire Inc.· Nov 17, 2026
- INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Medline Inc. - MDLNnegativeGlobeNewswire Inc.· Oct 13, 2026
- Bragar Eagel & Squire, P.C. is Investigating Medline Inc. on Behalf of Medline Stockholders and Encourages Investors to Contact the FirmnegativeGlobeNewswire Inc.· Oct 1, 2026
- INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Medline Inc. - MDLNnegativeGlobeNewswire Inc.· Sep 29, 2026
- MEDLINE INC. INVESTIGATION: MDLN Securities Investors Encouraged to Contact Kirby McInerney LLP About Their RightsnegativeGlobeNewswire Inc.· Sep 28, 2026
- NASDAQ: MDLN Investigation: Kessler Topaz Meltzer & Check, LLP Encourages Medline Inc. (NASDAQ: MDLN) Investors to Contact the FirmnegativeGlobeNewswire Inc.· Aug 7, 2026
Filings and the company
What Medline has disclosed to the SEC, and the basic facts about the listing.
8-K filings
Material events that Medline discloses to the SEC on Form 8-K.
- Public offeringNov 18, 2026
“the Company issued a press release that announced the pricing of an underwritten secondary offering ... of 60,000,000 shares of the Company's Class A common stock.” The Offering is expected to close on November 23, 2026, subject to customary closing conditions.
- Quarterly earningsNov 4, 2026
On November 4, 2026, Medline Inc. issued a press release announcing results for the third quarter and the first nine months ended September 26, 2026.
- Business line exitOct 21, 2026
On October 14, 2026, Medline Inc. initiated a voluntary field action involving the removal, discontinuation, and market exit of all Medline Brand beds, including homecare beds, bariatric beds, and long-term care beds, as well as their associated pendants, accessories, replacement parts, and bed-containing order packages. The affected products are within the Company's Front Line Care product category in the Company's Medline Brand segment.
- Director departureOct 15, 2026
On October 13, 2026, Joseph P. Baratta notified the Board of Directors (the "Board") of Medline Inc. (the "Company") of his decision to resign from the Board, effective as of December 31, 2026. Mr. Baratta's decision coincides with his previously announced departure from Blackstone Inc. and is not the result of any disagreement with the Company related to the Company's operations, policies, or practices.
- Executive officer departureJul 9, 2026
On July 7, 2026, Stephen L. Miller, Chief Operating Officer of Medline Inc. (the "Company"), notified the Company that he would retire from his role, effective August 30, 2026, for health-related reasons.
About Medline
Medline is the largest provider of medical-surgical products and supply chain solutions in the US. The company generates over 90% of its revenue domestically and serves some of the largest US health systems. Medline offers approximately 190,000 Medline-branded products across more than 250 product families—including front-line care, surgical solutions, and laboratory and diagnostics—as well as roughly 150,000 third-party products sourced from over 1,250 vendors. The company maintains prime vendor relationships with many customers, acting as the primary consolidated logistics partner for their medical-surgical needs. Medline has significant scale, supported by more than 30 manufacturing facilities and a fleet of over 2,000 owned delivery trucks. Medline went public in December 2025.
- Ticker
- MDLN
- Exchange
- Nasdaq
- Market
- stocks
- Type
- CS
- Currency
- USD
- Industry
- SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
- Employees
- 45K
- Listed
- Dec 17, 2025
- Security
- Ordinary Shares - Class A
Frequently asked questions
What was the Medline IPO price?
$29.00 a share.
When did Medline go public?
Medline listed on Nasdaq on Dec 17, 2025 under the ticker MDLN.
How much did the Medline IPO raise?
$7.2B, before any underwriters' option.
How did Medline open on its first day?
MDLN first traded at $35.00, +20.69% from the IPO price of $29.00.
How did MDLN close on its first day?
Its last regular-session trade was $40.66, +40.21% from the IPO price of $29.00.
What was the MDLN first-day trading range?
$34.89 to $41.25 in the regular session.
How many MDLN shares traded on the first day?
75.22M shares in the regular session.
How many shares did Medline sell in its IPO?
248.44M shares.
How did MDLN do against the market on its first day?
MDLN rose 16.2% from its first trade to the last trade of the session. That is 16.7 points better than the market (QQQ, the Nasdaq-100 ETF).
What exchange is MDLN listed on?
Medline lists on Nasdaq under the ticker MDLN.
Build with Massive
Get the MDLN data behind this page
| What the page shows | Endpoint |
|---|---|
| Offering terms and dates | /vX/reference/ipos |
| Price | /v3/snapshot |
| Chart, VWAP, and the market comparison | /v2/aggs/ticker/MDLN/range/5/minute |
| Market cap | /v3/reference/tickers/MDLN |
| News | /v2/reference/news |
| Filings | /vX/disclosures |
Nothing on this page is investment advice. All data and content is provided for informational purposes under our Terms of Service.